Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sylvia Josephy"'
Publikováno v:
Digital Biomarkers, Vol 5, Iss 1, Pp 9-15 (2020)
Introduction: Digital biomarkers may act as a tool for early detection of changes in cognition. It is important to understand public perception of technologies focused on monitoring cognition to better guide the design of these tools and inform patie
Externí odkaz:
https://doaj.org/article/041087c2cb7b42919b820c4c55899690
Publikováno v:
Neurobiology of Disease, Vol 97, Iss , Pp 139-155 (2017)
Neurodegenerative disorders are prevalent, complex and devastating conditions, with very limited treatment options currently available. While they manifest in many forms, there are commonalities that link them together. In this review, we will focus
Externí odkaz:
https://doaj.org/article/b50bcef604e546adbdf4048778c5578f
Autor:
Sylvia Josephy-Hernandez, Iulia Pirvulescu, Mario Maira, Tahar Aboulkassim, Tak Pan Wong, R Anne McKinney, H Uri Saragovi
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218036 (2019)
In the brain, the TrkA receptor for Nerve Growth Factor (NGF) is expressed primarily in the cholinergic system. TrkA/NGF support neuronal health and function, and deficiencies in this axis are associated with progressive cholinergic neuron atrophy an
Externí odkaz:
https://doaj.org/article/1ff36af77e7b4948ab6d293558c34c98
Autor:
Sylvia Josephy-Hernandez, Michael Brickhouse, Samantha Champion, David Dongkyung Kim, Alexandra Touroutoglou, Matthew Frosch, Bradford C. Dickerson
Publikováno v:
Neurocase. 28:375-381
Globular Glial Tauopathy (GGT) is a rare form of Frontotemporal Lobar Degeneration (FTLD) consisting of 4-repeat tau globular inclusions in astrocytes and oligodendrocytes. We present the pathological findings of GGT in a previously published case of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b60b472e22c4338b1ab318dc1fc6db
https://doi.org/10.1080/13554794.2022.2130805
https://doi.org/10.1080/13554794.2022.2130805
Autor:
Sylvia Josephy, Roy Hamilton
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e05e3d48f0b3d905458b16a4ef4ca5d9
https://doi.org/10.1212/wnl.0000000000203071
https://doi.org/10.1212/wnl.0000000000203071
Autor:
Mark Basik, Jacek Majewski, Catalin Mihalcioiu, Elizabeth A. Marcus, André Robidoux, Josée-Anne Roy, Peter Tonellato, Sheida Nabavi, Eric Bareke, Christoph H. Borchers, René P. Zahedi, Vincent R. Richard, Stephen D. Hursting, Ciara O'Flanagan, Sylvia Josephy, Horace Uri Saragovi, Moulay Alaoui-Jamali, Amine Saad, Naciba Benlimame, Marie-Christine Guilbert, Cristiano Ferrario, Olga Aleynikova, Luca Cavallone, Urszula Krzemien, Cathy Lan, Ewa Przybytkowski, Stéphanie Légaré, Banujan Balachandran, Aparna Ramanathan, Catherine Chabot, Marguerite Buchanan, Michelle Scriver, Viet Vu, Emma Fowler, Josiane Lafleur, Adriana Aguilar-Mahecha, Isabelle Sirois
Supplementary Figure 1 a. Doxorubicin resistance of DOXO-R C8 cells was further validated using the cell viability assay (SRB) following 48 hrs treatment with DOXO, n=4 independent experiment, 3 replicates/experiment. **p0.6 and pval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5951da76f101d8988229319ab24ea931
https://doi.org/10.1158/1541-7786.22515963
https://doi.org/10.1158/1541-7786.22515963
Autor:
Mark Basik, Jacek Majewski, Catalin Mihalcioiu, Elizabeth A. Marcus, André Robidoux, Josée-Anne Roy, Peter Tonellato, Sheida Nabavi, Eric Bareke, Christoph H. Borchers, René P. Zahedi, Vincent R. Richard, Stephen D. Hursting, Ciara O'Flanagan, Sylvia Josephy, Horace Uri Saragovi, Moulay Alaoui-Jamali, Amine Saad, Naciba Benlimame, Marie-Christine Guilbert, Cristiano Ferrario, Olga Aleynikova, Luca Cavallone, Urszula Krzemien, Cathy Lan, Ewa Przybytkowski, Stéphanie Légaré, Banujan Balachandran, Aparna Ramanathan, Catherine Chabot, Marguerite Buchanan, Michelle Scriver, Viet Vu, Emma Fowler, Josiane Lafleur, Adriana Aguilar-Mahecha, Isabelle Sirois
Table S18: Two-way ANOVA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee4709fac1d7833473c13afa1ca590d
https://doi.org/10.1158/1541-7786.22515954.v1
https://doi.org/10.1158/1541-7786.22515954.v1
Autor:
Mark Basik, Jacek Majewski, Catalin Mihalcioiu, Elizabeth A. Marcus, André Robidoux, Josée-Anne Roy, Peter Tonellato, Sheida Nabavi, Eric Bareke, Christoph H. Borchers, René P. Zahedi, Vincent R. Richard, Stephen D. Hursting, Ciara O'Flanagan, Sylvia Josephy, Horace Uri Saragovi, Moulay Alaoui-Jamali, Amine Saad, Naciba Benlimame, Marie-Christine Guilbert, Cristiano Ferrario, Olga Aleynikova, Luca Cavallone, Urszula Krzemien, Cathy Lan, Ewa Przybytkowski, Stéphanie Légaré, Banujan Balachandran, Aparna Ramanathan, Catherine Chabot, Marguerite Buchanan, Michelle Scriver, Viet Vu, Emma Fowler, Josiane Lafleur, Adriana Aguilar-Mahecha, Isabelle Sirois
Table S1: List of regions of genes with increased CNV (>= 0.5) and gene expression (>= 0.5) in DOXO-R cells compared to parental cells Table S2: List of all fold change and pvalue of DOXO-R C1 and C8 (vs parental cells) from gene expression analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14ecb9da2642b74d4a5b22b716b9132
https://doi.org/10.1158/1541-7786.22515957.v1
https://doi.org/10.1158/1541-7786.22515957.v1
Autor:
Mark Basik, Jacek Majewski, Catalin Mihalcioiu, Elizabeth A. Marcus, André Robidoux, Josée-Anne Roy, Peter Tonellato, Sheida Nabavi, Eric Bareke, Christoph H. Borchers, René P. Zahedi, Vincent R. Richard, Stephen D. Hursting, Ciara O'Flanagan, Sylvia Josephy, Horace Uri Saragovi, Moulay Alaoui-Jamali, Amine Saad, Naciba Benlimame, Marie-Christine Guilbert, Cristiano Ferrario, Olga Aleynikova, Luca Cavallone, Urszula Krzemien, Cathy Lan, Ewa Przybytkowski, Stéphanie Légaré, Banujan Balachandran, Aparna Ramanathan, Catherine Chabot, Marguerite Buchanan, Michelle Scriver, Viet Vu, Emma Fowler, Josiane Lafleur, Adriana Aguilar-Mahecha, Isabelle Sirois
The major obstacle in successfully treating triple-negative breast cancer (TNBC) is resistance to cytotoxic chemotherapy, the mainstay of treatment in this disease. Previous preclinical models of chemoresistance in TNBC have suffered from a lack of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8977b5f5ea9cc4145130c77246c005e6
https://doi.org/10.1158/1541-7786.c.6541230
https://doi.org/10.1158/1541-7786.c.6541230